Daurismo Prices, Coupons, Copay Cards & Patient Assistance
Daurismo (glasdegib) is a member of the hedgehog pathway inhibitors drug class and is commonly used for Acute Myeloid Leukemia.
The cost for Daurismo 25 mg oral tablet is around $23,643 for a supply of 60 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Daurismo is available as a brand name drug only, a generic version is not yet available. View generic Daurismo availability for more details.
Daurismo prices
Oral Tablet
25 mg
Daurismo oral tablet
from $23,642.76
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $394.05 | $23,642.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
100 mg
Daurismo oral tablet
from $23,642.76
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $788.09 | $23,642.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Daurismo Coupons, Copay Cards and Rebates
Daurismo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Healthcare providers may request samples of Daurismo by logging onto the PfizerPro website or by calling 800-505-4426.
- Applies to:
- Daurismo
- Number of uses:
- Contact the program
Form more information phone: 800-505-4426 or Visit website
Daurismo Pfizer Oncology Together Co-Pay Savings Program
Eligible commercially insured patients may pay as little as $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.
- Applies to:
- Daurismo
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Daurismo Pfizer Oncology Together Mail-In Rebate
If a pharmacy does not accept the Savings Card the patient may submit a request for a rebate in connection with the offer; for additional information contact the program at 877-744-5675.
- Applies to:
- Daurismo
- Number of uses:
- One rebate per prescription fill
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Patient Assistance & Copay Programs for Daurismo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Daurismo (glasdegib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Pfizer Patient Assistance Program
Eligibility requirements:- Uninsured or Underinsured
- Varies
- Not specified
- Must be residing in the US or US territory
- Pfizer also has programs that provide eligible patients with insurance, support assistance, and medicines at a savings. Contact Pfizer RxPathways for details (844-989-7284).
- Daurismo (glasdegib) Tablet
More information please phone: 866-706-2400 Visit Website
Provider: Pfizer Oncology Together
Eligibility requirements:- Contact program for details.
- At or below 300% of FPL
- FDA-approved diagnosis
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Daurismo (glasdegib) Tablet
More information please phone: 877-744-5675 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Daunorubicin
Daunorubicin systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, acute ...
Revumenib
Revumenib systemic is used for acute lymphoblastic leukemia, acute myeloid leukemia, leukemia
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
More about Daurismo (glasdegib)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español